<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心签名</title><link/>https://pubed.nlm.nlm.nlm.gov/rss-feed/?feed_id = 1VUEPJ4Z_TESAAXKWJXBOGOTAAB-NVU8000KRRCPQ8YLQ-＆utm_SOUTM_SOURM_SOURCE = CHROME&amp;ff=202020202020202020202020202020 C = 20230814047＆utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAAB-NVU8000KRCPQ-＆utm_MEDIUM = SRS＆V = 2.18.0.e<description>心血管高分期刊：Pubed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;ff=20250309161020&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> enthing</language><lastbuilddate>太阳，2025年3月9日20:10:21 +0</lastbuilddate><pubDate> Sat, 08 Mar 2025 06:00:00 -0500</pubDate><ttl> 120</ttl><item><title> Corv-A野生考拉的转录沉默的演变</title><link/>https://pubed.ncbi.nlm.nlm.gov/40056902/？ 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>考拉逆转录病毒-A（KORV-A）在北到南波中通过考拉弹出，同时转导生殖系，将遗传基因组修改为过渡到末端逆转录病毒。以前，我们发现KRV-A在种系中表达，但是未填充的基因组转录本被处理为有感觉链PIWI-PIWI-PIWI-PIWI-PIWI-RNA（PINAS），该RNA（PINAS）可能会提供转录后SILNScription的nnial“先天”形式。在这里，我们表明最初的转录后响应。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>2025年2月26日：S0092-8674（25）0 doi：10.1016/j.cell.2025.0在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">考拉逆转录病毒-A（KORV-A）在北到南波中通过考拉弹出，同时转导生殖系，将遗传基因组修改为过渡到末端逆转录病毒。以前，我们发现KRV-A在种系中表达，但是未填充的基因组转录本被处理为有感觉链PIWI-PIWI-PIWI-PIWI-PIWI-RNA（PINAS），该RNA（PINAS）可能会提供转录后SILNScription的nnial“先天”形式。在这里，我们表明，这种最初的转录后反应在布里斯班河以南普遍存在，在该河中表达的Krriv-A被抑制了，启动子是方法，在河流的亚种群中，Pirrans同样丰富。 MAP4K4基因的3&#39;UTR中有多少动物，该动物正在通过北部的北部散布，并产生混合转录本，这些转录本被加工到Ansense Pirnas中，这些杂种引导了转录的sillencing。我们指出，这是这种概率触发了KRV-A的自适应转录幅度，并且对固定很甜蜜。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40056902/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40056902</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.02.006>10.1016/j.cell.2025.0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Sat, 08 Mar 2025 06:00:00 -0500</pubDate><dc:creator>坦率</dc:creator><dc:creator>Michaela BJ Blyton</dc:creator><dc:creator>乳白色Abajorga</dc:creator><dc:creator> Birit S Koppetsch</dc:creator><dc:creator>萨曼莎·何</dc:creator><dc:creator>Bo Xu</dc:creator><dc:creator>宗族胡</dc:creator><dc:creator>杰里米·卢本（Jeremy Luban）</dc:creator><dc:creator>基思·查佩尔（Keith Chappell）</dc:creator><dc:creator> Zhiping声音</dc:creator><dc:creator>William E Theurka​​uf</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>细胞</dc:source><dc:title>Corv-A野生考拉的转录沉默的演变</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1016/j.2025.0</dc:identifier></item><item><title>饮食植物小分子的功能多样性通过肠道微型分子</title><link/>https://pubmed.nlm.nih.gov/40056901/?utm_source = chrome＆utm_medium = rss＆outm_campaign = pubed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>植物由与人类健康相关的多种二级代谢产物（PSS）组成。肠道是否以及如何微观供电的PSM的社交ikact被理解不足。在这里，我们表明，离散的饮食和药用电话Phalec糖苷（大量与健康相关的PSM）被人类肠道微che的成员使用。在细菌中，西方人类肠道的主要革兰氏阴性细菌，我们揭示了一种专门的多酶系统。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>2025年2月28日：S0092-8674（25）0155-2 doi：10.1016/j.cell.2025.01.0在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">植物由与人类健康相关的多种二级代谢产物（PSS）组成。肠道是否以及如何微观供电的PSM的社交ikact被理解不足。在这里，我们表明，离散的饮食和药用电话Phalec糖苷（大量与健康相关的PSM）被人类肠道微che的成员使用。在细菌剂中，西方人类肠道的主要革兰氏阴性细菌，我们获得了一种专门的多酶系统，该系统专门用于基于酚类部分的结构差异来处理脱糖苷。这种菌核化代谢系统化学分解了多种生物学功能，将其作为对肠道抗胆汁剂的抗性性抗性性的抗性性，多丁蛋白向高脂蛋白的多丁素的芳族微生物激活。盐酸盐盐盐酸酯盐。总之，我们的结果表明，通过独特的肠道微粒编码的PSM加工系统，酚酚AgLamcOne“效应剂”功能的生物学多样性产生。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40056901/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40056901</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.01.045>10.1016/j.cell.2025.0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Sat, 08 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Gavin A Kuziel</dc:creator><dc:creator> Gabriel L Lozano</dc:creator><dc:creator> Corina Simian</dc:creator><dc:creator>长李</dc:creator><dc:creator>约翰·曼尼昂</dc:creator><dc:creator>Emmanuel Stephen-Victor</dc:creator><dc:creator> Talal Chatila</dc:creator><dc:creator> Min Dongong</dc:creator><dc:creator>王王</dc:creator><dc:creator>塞思·拉科夫·纳胡姆（Seth Rakoff-Nahoum）</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>细胞</dc:source><dc:title>饮食植物小分子的功能多样性通过肠道微型分子</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1016/j.2025.0</dc:identifier></item><item><title>大争论：经皮冠状动脉干预后，急性冠状动脉综合征的DAL抗血小板治疗持续时间应为12个月</title><link/>https://pubmed.nlm.nlm.gov/40056109/?utm_source=Chrome&amp;utm_medium = rsss＆outm_campaign = pubbed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月8日：EHAF0 doi：10.1093/eurheartj/ehaf0在线印刷。</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40056109/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40056109</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf070>10.1093/eurheartj/ehaf0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Sat, 08 Mar 2025 06:00:00 -0500</pubDate><dc:creator>罗伯特·伯恩（Robert Byrne）</dc:creator><dc:creator> Marco Valgimigli</dc:creator><dc:creator> Deepak L Bhatt</dc:creator><dc:creator> JJ咳嗽咳嗽</dc:creator><dc:creator>C迈克尔·吉布森</dc:creator><dc:creator>Xavier Rossello</dc:creator><dc:creator>戴安娜（Diana）的戈罗格（Gorog）</dc:creator><dc:creator> Borja Ibanez</dc:creator><dc:creator> Stefan James</dc:creator><dc:creator>安东尼奥·兰迪</dc:creator><dc:creator>P Gabriel Steg</dc:creator><dc:creator> Gregg W Stoneg Walne</dc:creator><dc:creator> Felicita Andreotti</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>大争论：经皮冠状动脉干预后，急性冠状动脉综合征的DAL抗血小板治疗持续时间应为12个月</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf0</dc:identifier></item><item><title>鱼类对深海的进化和遗传适应</title><link/>https://pubed.ncbi.nlm.nlm.gov/40054449/？ 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>深海，尤其是半成区的区域，其特征是高静态压力，低晶状体和近乎发现的黑暗，呈现出地球上生命中最具挑战性的一些环境。霍弗（Howver），Teleps Fish通过复杂的适应性成功地殖民了这些极端栖息地。我们生成了12种的基因组组件，其中包括11种深海鱼类。我们的发现重建了Teleosa殖民历史，并揭示了深海环境的整体影响。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>2025年3月6日； 188（5）：1393-1408.e1 doi：10.1016/j.cell.2025.0</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">深海，尤其是半成区的区域，其特征是高静态压力，低晶状体和近乎发现的黑暗，呈现出地球上生命中最具挑战性的一些环境。霍弗（Howver），Teleps Fish通过复杂的适应性成功地殖民了这些极端栖息地。我们生成了12种的基因组组件，其中包括11种深海鱼类。我们的发现重建了Teleosa殖民历史，并揭示了深海环境对鱼类的总体影响。有趣的是，我们的结果质疑先前假定的三甲基氧化物（TMAO）含量和深度之间的线性相关性。相比之下，我们观察到在大多数3,000 m以下的深海鱼类中，RTF1基因中的收敛AA替换，并且体外实验表明该突变会影响转录效率，这在深海环境中可能是有利的。此外，我们的研究强调了人类活动的普遍影响，因为我们发现玛丽亚·特林奇（Maria Trinch）物种中存在持续的有机污染物。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40054449/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40054449</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.01.002>10.1016/j.cell.2025.0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator>韩Xu</dc:creator><dc:creator> Chengchi Fang</dc:creator><dc:creator> Yesjie Xu</dc:creator><dc:creator>王王</dc:creator><dc:creator>Yee歌</dc:creator><dc:creator>王子</dc:creator><dc:creator>Wenyu Fang</dc:creator><dc:creator>广态粉丝</dc:creator><dc:creator>大喊LV</dc:creator><dc:creator> Jing Bo</dc:creator><dc:creator>韩国Zeng</dc:creator><dc:creator>智莎</dc:creator><dc:creator>Helu Liu</dc:creator><dc:creator> Hongmei Jing</dc:creator><dc:creator>刘</dc:creator><dc:creator>Manoshu Wei</dc:creator><dc:creator> Jiwei li</dc:creator><dc:creator>莉山</dc:creator><dc:creator>Shanya Cai</dc:creator><dc:creator> Xaoni gan</dc:creator><dc:creator> Yiyu Chin</dc:creator><dc:creator> Haibin Zhang</dc:creator><dc:creator>我不确定是</dc:creator><dc:creator>驳回他</dc:creator><dc:date>2025-03-0</dc:date><dc:source>细胞</dc:source><dc:title>鱼类对深海的进化和遗传适应</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1016/j.2025.0</dc:identifier></item><item><title> Amphipod基因组揭示了人口动态和研究环境的适应</title><link/>https://pubmed.nlm.nih.gov/40054448/?utm_source=Chrome&amp;utm_medium = rss＆outm_campaign=pubbed-2&amp;utm_content= 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description> Amphipod Hirondellea Gigas是居住在海洋中死亡部分（约6,800-11,000 m）的主要物种，但对其遗传适应性和种群动态知之甚少。在这里，我们提出了H. gigas的染色体水平基因组，其特征是大型基因组大小为13.92 GB。来自玛丽安娜（Mariana）沟渠的510个个体的WHO基因组测序表明，深度没有种群的差异，这表明其耐受静水压力范围的能力。 H. Gigas。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>2025年3月6日； 188（5）：1378-1392.E1 doi：10.1016/j.cell.2025.0</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Amphipod Hirondellea Gigas是居住在海洋中死亡部分（约6,800-11,000 m）的主要物种，但对其遗传适应性和种群动态知之甚少。在这里，我们提出了H. gigas的染色体水平基因组，其特征是大型基因组大小为13.92 GB。来自玛丽安娜（Mariana）沟渠的510个个体的WHO基因组测序表明，深度没有种群的差异，这表明其耐受静水压力范围的能力。西盆地的H. gigas在遗传上与玛丽安娜和Yap沟渠有分歧，这暗示着与Stalbad特征的地理分离的隔离属性。有效人口大小的急剧减少反映了冰川冰川嵌片。通过整合多摩学分析，我们提出了宿主 - 合成微生物相互作用，对于将H. gigas适应极高的高压和食物限制环境可能至关重要。我们的发现提供商的线索适应了区域和人口遗传学。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40054448/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40054448</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.01.030>10.1016/j.cell.2025.0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Haibin Zhang</dc:creator><dc:creator> Shuai Sun</dc:creator><dc:creator> Jun Liu</dc:creator><dc:creator> Qunfei guo</dc:creator><dc:creator> Liang Meng</dc:creator><dc:creator> Jianwei Cheny</dc:creator><dc:creator> Xueyan Xang</dc:creator><dc:creator>杨周</dc:creator><dc:creator>南南张</dc:creator><dc:creator>Helu Liu</dc:creator><dc:creator> Yalin Liu</dc:creator><dc:creator>吉昂·杨</dc:creator><dc:creator>Qianyue ji</dc:creator><dc:creator>莉山</dc:creator><dc:creator>Shanya Cai</dc:creator><dc:creator>金阳凯</dc:creator><dc:creator>Xin Huang</dc:creator><dc:creator> Shiyu Xu</dc:creator><dc:creator> yumylu xiao</dc:creator><dc:creator> Yangrui Zhang</dc:creator><dc:creator>我不确定是</dc:creator><dc:creator>刘吉</dc:creator><dc:creator>Haixin Chin</dc:creator><dc:creator> Zhen Yue</dc:creator><dc:creator>驳回他</dc:creator><dc:creator>王王</dc:creator><dc:creator>阳阳</dc:creator><dc:creator>新刘</dc:creator><dc:creator>英格·塞姆（Inge Seim）</dc:creator><dc:creator> ying gu</dc:creator><dc:creator> Qiye li</dc:creator><dc:creator> Gujie Zhang</dc:creator><dc:creator> Simon Ming-Yuen Lee</dc:creator><dc:creator> Karsten Kristansen</dc:creator><dc:creator> Xun Xu</dc:creator><dc:creator> Shanshan Liu</dc:creator><dc:creator>广态粉丝</dc:creator><dc:date>2025-03-0</dc:date><dc:source>细胞</dc:source><dc:title>Amphipod基因组揭示了人口动态和研究环境的适应</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1016/j.2025.0</dc:identifier></item><item><title>最深的海洋沉积物中的微生物生态系统和生态驱动力</title><link/>https://pubed.ncbi.nlm.nlm.gov/40054447/?utm_source = chrome&amp;utm_medium = rsss＆outm_campaign = pubaign = pubbed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>地震海洋领域对阿格达拉德地区的收缩探索历史上存在着技术限制。在这里，我们在玛丽安娜·特林奇（Mariana Trinch），Yap Trench，菲律宾盆地（Mariana Trinch Enighting and Ecology Research（Meer）项目（MEER）项目）中收集了1,648个沉积物样品。 MEER数据集，包括7,564种（未报告89.4％），表明高分类性新颖。与报告的环境不同。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>2025年3月6日； 188（5）：1363-1377.e9 doi：10.1016/j.cell.2024.12.0</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">地震海洋领域对阿格达拉德地区的收缩探索历史上存在着技术限制。在这里，我们在玛丽安娜·特林奇（Mariana Trinch），Yap Trench，菲律宾盆地（Mariana Trinch Enighting and Ecology Research（Meer）项目（MEER）项目）中收集了1,648个沉积物样品。 MEER数据集，包括7,564种（未报告89.4％），表明高分类性新颖。与报道的环境不同，中性漂移起着最小的作用，而均质选择（HOS，50.5％）和分散限制（DL，43.8％）作为主要的生态驱动因素出现。 HOS有利于具有关键功能的简化基因组，例如hyad适应性，例如芳香族化合物利用率（贫营养适应性）和抗氧化（高压适应性）。对话，DL促进了具有较大基因组的多功能代谢。这一结局如何表明环境因素推动了哈拉德地区的高分类新颖性，从而促进了我们对这种极端海洋环境中管理微型稳定的生态机制的理解。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40054447/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40054447</a> | doi： <a href=https://doi.org/10.1016/j.cell.2024.12.036>10.1016/j.cell.2024.12.036</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator>杨小子</dc:creator><dc:creator>Weishu Zhao</dc:creator><dc:creator> Zewei歌曲</dc:creator><dc:creator>Qi Qi</dc:creator><dc:creator>博·王</dc:creator><dc:creator>朱伊朱</dc:creator><dc:creator>詹姆斯·詹姆斯·林</dc:creator><dc:creator>王王</dc:creator><dc:creator>Aoran Hu</dc:creator><dc:creator> Shanshan Huang</dc:creator><dc:creator> Yinzhao Wang</dc:creator><dc:creator> Jianwei Cheny</dc:creator><dc:creator> Chao Fang</dc:creator><dc:creator> Qianyue ji</dc:creator><dc:creator>南南张</dc:creator><dc:creator>Liang Meng</dc:creator><dc:creator>小韦</dc:creator><dc:creator>chuanxu下巴</dc:creator><dc:creator>Shanya Cai</dc:creator><dc:creator>春</dc:creator><dc:creator>康丁</dc:creator><dc:creator>李李</dc:creator><dc:creator>Shuangquan Liu</dc:creator><dc:creator>塔拉兰的歌</dc:creator><dc:creator>Liyang Tian</dc:creator><dc:creator> Haibin Zhang</dc:creator><dc:creator> Zhang</dc:creator><dc:creator> Shiyu Xu</dc:creator><dc:creator> jiayu下巴</dc:creator><dc:creator>Haixin Chin</dc:creator><dc:creator> QIAN CEN</dc:creator><dc:creator>方芳江</dc:creator><dc:creator>瓜厄胡</dc:creator><dc:creator>Chenguang Tang</dc:creator><dc:creator>吴郭</dc:creator><dc:creator>王王</dc:creator><dc:creator>zhan</dc:creator><dc:creator> Jie粉丝</dc:creator><dc:creator>Jun Wang</dc:creator><dc:creator>长豪</dc:creator><dc:creator>liuyang li</dc:creator><dc:creator> Zhenbo LV</dc:creator><dc:creator> Yaoxun Hu</dc:creator><dc:creator>小衬里</dc:creator><dc:creator>Guoqiang Mai</dc:creator><dc:creator> Lilin Luo</dc:creator><dc:creator>杨</dc:creator><dc:creator>Weiwen Wang</dc:creator><dc:creator> Karsten Kristansen</dc:creator><dc:creator> Liqun Chen</dc:creator><dc:creator>阳阳</dc:creator><dc:creator>明尼尼</dc:creator><dc:creator>ying gu</dc:creator><dc:creator>冯穆</dc:creator><dc:creator>Yunfeng Yang</dc:creator><dc:creator> Jizhong Zhou</dc:creator><dc:creator>王王</dc:creator><dc:creator>Wei-Jia Zhang</dc:creator><dc:creator>莫汉</dc:creator><dc:creator>Xun Xu</dc:creator><dc:creator> Shanshan Liu</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>细胞</dc:source><dc:title>最深的海洋沉积物中的微生物生态系统和生态驱动力</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1016/j.2024.12.036</dc:identifier></item><item><title>在几天内采样代表性塑料运动可以实现长期神经假体控制</title><link/>https://pubmed.nlm.nih.gov/40054446/?utm_source = chrome&amp;utm_medium = rsss＆outm_campaign = pubed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>神经系统需要平衡神经代表的稳定性与可塑性。叔叔是简单训练的行动的代表性稳定性，尤其是在人类中，以及它们对新环境的适应性。使用四翼型参与者中的电皮质学脑部计算机Interace（BCI），我们发现简单诱发曲目的低维歧管和相对表示非常稳定。这... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>2025年3月6日； 188（5）：1208-1225.e3 doi：10.1016/j.cell.2025.0</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">神经系统需要平衡神经代表的稳定性与可塑性。叔叔是简单训练的行动的代表性稳定性，尤其是在人类中，以及它们对新环境的适应性。使用四翼型参与者中的电皮质学脑部计算机Interace（BCI），我们发现简单诱发曲目的低维歧管和相对表示非常稳定。然而，歧管的绝对位置证明了这一漂移的限制。可能会灵活地调节神经统计数据，尤其是方差，以增加用Soutopic Charasib在BCI替代期间的代表性距离。具有实践支持的可辨认性，并且是特定于BCI的，并说明了上下文。对代表性塑料进行采样并在几天内漂移，随后发现了元代表性结构，并具有可概括的曲目决策界限；这允许对机器人手臂的长期神经假体控制和手伸入和抓握。我们的研究对中尺度代表统计的洞察力也可以实现长期复杂的神经假体控制。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40054446/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40054446</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.02.001>10.1016/j.cell.2025.0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Nikhilesh Nattraj</dc:creator><dc:creator> Sarah Seko Seko</dc:creator><dc:creator> Reza Abiri</dc:creator><dc:creator> Runfeng Miao</dc:creator><dc:creator> Hontyi Yan</dc:creator><dc:creator> Yasmin Graham</dc:creator><dc:creator>阿德琳·图坎</dc:creator><dc:creator>爱德华·F·张</dc:creator><dc:creator>卡伦什·甘加利（Karunesh Ganguly）</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>细胞</dc:source><dc:title>在几天内采样代表性塑料运动可以实现长期神经假体控制</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1016/j.2025.0</dc:identifier></item><item><title>从大数据和实验模型到临床试验：微型研究的迭代策略</title><link/>https://pubed.ncbi.nlm.nlm.gov/40054445/？ 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>在过去的二十年中，MicroMe研究一直在扩展，但转换为临床应用仍然具有挑战性。该观点讨论了微型研究中的相关研究的持续问题，并提出了在硅，体外，Ex Vivo和体内研究中的迭代甲基甲基化杠杆作用。研究的发展，包括从小型队列研究向大规模的转变。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>2025年3月6日； 188（5）：1178-1 doi：10.1016/j.cell.2025.01.0</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">在过去的二十年中，MicroMe研究一直在扩展，但转换为临床应用仍然具有挑战性。该观点讨论了微型研究中的相关研究的持续问题，并提出了在硅，体外，Ex Vivo和体内研究中的迭代甲基甲基化杠杆作用。研究方法的演变，包括从小型队列研究转变为大规模，多核病，甚至“元元素”分析的转变，一项研究中的健康表型。将多词的方法和元基因组学，Metateranscriptrolomics，荟萃蛋白质组学和Metaboomics-provides的整合整合，以全面了解宿主 - 微生物相互作用，并用作稳健的杂种和在体内的耐用性。然后必须严格测试这些降低，首先是通过固定实验实验来阐明微生物群的致病作用，然后是深层机械理解的目的。仅遵循阶段才能承认临床前研究，以转化为诊所。我们强调了将传统微生物技术与大数据使用方法相结合的重要性，强调了在不同模型系统中迭代实验的必要性，以增强Microme研究的转化潜力。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40054445/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">400544445</a> | doi： <a href=https://doi.org/10.1016/j.cell.2025.01.038>10.1016/j.cell.2025.0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator>桑德拉·图杰曼（Sondra Turjeman）</dc:creator><dc:creator>托马索·罗泽拉（Tommaso Rozera）</dc:creator><dc:creator> Eran Elinav</dc:creator><dc:creator> Gianluca Ianiro</dc:creator><dc:creator>哦，肯</dc:creator><dc:date>2025-03-0</dc:date><dc:source>细胞</dc:source><dc:title>从大数据和实验模型到临床试验：微型研究的迭代策略</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.0</dc:identifier></item><item><title> Meer：在最深的海洋中非凡的繁荣生态系统</title><link/>https://pubed.ncbi.nlm.nlm.gov/400544444/?utm_source = chrome&amp;utm_medium = rsss＆outm_campaign = pubed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>在这里，我们介绍了Mariana Trench环境和生态研究（MEER）项目，该项目提供了该区域生态系统的第一个系统观点。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>细胞</b>2025年3月6日； 188（5）：1175-1 doi：10.1016/j.cell.2024.12.0</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">在这里，我们介绍了Mariana Trench环境和生态研究（MEER）项目，该项目提供了该区域生态系统的第一个系统观点。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40054444/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40054444</a> | doi： <a href=https://doi.org/10.1016/j.cell.2024.12.037>10.1016/j.cell.2024.12.037</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator>杨小子</dc:creator><dc:creator>王王</dc:creator><dc:creator>康丁</dc:creator><dc:date>2025-03-0</dc:date><dc:source>细胞</dc:source><dc:title>Meer：在最深的海洋中非凡的繁荣生态系统</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1016/j.cell.2024.12.037</dc:identifier></item><item><title>斑块侵蚀风险和JAK2 V617F变体</title><link/>https://pubed.ncbi.nlm.nlm.gov/40053703/？ 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>结论：JAK2 V617F的侵蚀风险很高，并且增强中性粒细胞的激活有助于这种侵蚀。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日：EHAF1 doi：10.1093/eurheartj/ehaf1在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景和目的：不确定潜力（CHIP）的克隆止血作用可以增加心肌梗塞（MI）的风险。在Vararus芯片突变中，JAK2 V617F显着升高了这种风险。然而，JAK2 V617F与我们的两种机制之间的特定关联，斑块侵蚀和斑块破裂尚不清楚。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHS：病例对照研究研究了这些关联。我们中心包括728例侵蚀病例，919例破裂病例和804个对照。对这些个体进行了数字吸收聚合酶链反应，以识别JAK2 V6的存在以前的实验工作已将中性粒细胞暗示在这种突变存在下侵蚀的发病机理中。因此，进行了来自JAK2 V617F载体和健康供体的中性粒细胞的单细胞RNA测序，以寻求负责与JAK22 V6相关的侵蚀的潜在机制</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在参与者中，有26名（3.57％）侵蚀患者，7（.76％）破裂患者和3（.37％）对照对照组为JAK2 V6侵蚀性患者中的载体表现出高血小板计数，血红蛋白和血脂水平较低。逻辑回归分析（将侵蚀或破裂视为单独的情况）表明，vaf≥1％的JAK2 V617F载体显示出与ERISION的签名相关[优势比（OR）16.246，95％置信度（CI） &lt;.0001]，但没有破裂（或1.677，95％CI .379-7.415，p = .495）。单细胞RNA序列数据表明，来自JAK2 V617F载体的中性粒细胞显示出与激活，粘附，迁移和Granle分泌相关的基因和基因集的表达水平。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：JAK2 V617F的侵蚀风险很高，并且增强中性粒细胞的激活有助于这种侵蚀。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40053703/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40053703</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf114>10.1093/eurheartj/ehaf1</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Shengfang Wang</dc:creator><dc:creator> Xing Luo</dc:creator><dc:creator>胡</dc:creator><dc:creator>Chen Zhao</dc:creator><dc:creator> Qianhui Sun</dc:creator><dc:creator>明Zeng</dc:creator><dc:creator>小宝</dc:creator><dc:creator>Yini Wang</dc:creator><dc:creator> fangfang Wu</dc:creator><dc:creator> Yeqiu Yang</dc:creator><dc:creator> ying lv</dc:creator><dc:creator> Xiaoxuan bai</dc:creator><dc:creator> Wei Hao</dc:creator><dc:creator> Minghao Liu</dc:creator><dc:creator> boling yi</dc:creator><dc:creator> Yuwu下巴</dc:creator><dc:creator>魏门</dc:creator><dc:creator>Ji li li</dc:creator><dc:creator>李</dc:creator><dc:creator>姜黄金</dc:creator><dc:creator>天吴武</dc:creator><dc:creator>Yipin Zhao</dc:creator><dc:creator>张张</dc:creator><dc:creator>仁安</dc:creator><dc:creator>彼得·利比</dc:creator><dc:creator>Haibo Jia</dc:creator><dc:creator> Bo Yu</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>斑块侵蚀风险和JAK2 V617F变体</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf1</dc:identifier></item><item><title>性别特异性关联和循环蛋白质中的梗塞：潜在的因果关系</title><link/>https://pubed.ncbi.nlm.nlm.gov/40053702/？ 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日：EHAF1 doi：10.1093/eurheartj/ehaf1在线印刷。</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40053702/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40053702</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf111>10.1093/eurheartj/ehaf1</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Yi Xu</dc:creator><dc:creator>天普冯</dc:creator><dc:creator>Yuanyuan Huang</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>性别特异性关联和循环蛋白质中的梗塞：潜在的因果关系</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf1</dc:identifier></item><item><title>一种新型的经皮技术，用于闭合肺动脉静脉动脉的异常左冠状动脉起源</title><link/>https://pubmed.nlm.nih.gov/40053696/?utm_source=Chrome&amp;utm_medium = rsss＆outm_campaign = pubed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日：EHAF0 doi：10.1093/eurheartj/ehaf0在线印刷。</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40053696/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40053696</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf090>10.1093/eurheartj/ehaf0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Shubo歌曲</dc:creator><dc:creator>Liyun Zhao</dc:creator><dc:creator> Taibing粉丝</dc:creator><dc:date>2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>一种新型的经皮技术，用于闭合肺动脉静脉动脉的异常左冠状动脉起源</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf0</dc:identifier></item><item><title>循环蛋白质和事件的心肌梗塞：评估性别特定的差异和因果关系</title><link/>https://pubmed.nlm.nih.gov/40053693/?utm_source = chrome＆utm_medium = rss＆outm_campaign = pubed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日：EHAF1 doi：10.1093/eurheartj/ehaf1在线印刷。</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40053693/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40053693</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf113>10.1093/eurheartj/ehaf1</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Olga E Titova</dc:creator><dc:creator> Shuai Yuan</dc:creator><dc:creator> Liisa Byberg</dc:creator><dc:creator>约翰男爵。</dc:creator><dc:creator>拉尔斯·林德（Lars Lind）</dc:creator><dc:creator> KarlMichaëlsson</dc:creator><dc:creator> Susanna C Larsson</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>循环蛋白质和事件的心肌梗塞：评估性别特定的差异和因果关系</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf1</dc:identifier></item><item><title>冠状病毒疾病疫苗接种后心血管事件的可能观点</title><link/>https://pubmed.nlm.nih.gov/40053691/?utm_source = chrome&amp;utm_medium = rss＆outm_campaign = pubed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日：EHAF1 doi：10.1093/eurheartj/ehaf1在线印刷。</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40053691/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40053691</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf112>10.1093/eurheartj/ehaf1</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Xue-Yan Gong</dc:creator><dc:creator>詹姆斯·郑钟魏</dc:creator><dc:creator>张张</dc:creator><dc:date>2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>冠状病毒疾病疫苗接种后心血管事件的可能观点</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf1</dc:identifier></item><item><title>专注于运动员的冠状动脉粥样硬化，非刺激性冠状动脉，急性血管综合征的机制和Marfan综合征的机制</title><link/>https://pubmed.nlm.nih.gov/400533441/?utm_source=Chrome&amp;utm_medium = rsss＆outm_campaign = pubed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日； 46（10）：877-8 doi：10.1093/eurheartj/ehaf0</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40053441/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40053441</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf055>10.1093/eurheartj/ehaf055</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Filipippo Crea</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>专注于运动员的冠状动脉粥样硬化，非刺激性冠状动脉，急性血管综合征的机制和Marfan综合征的机制</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf0</dc:identifier></item><item><title>推动边界：管理110年患者的未知领域</title><link/>https://pubed.ncbi.nlm.nlm.gov/40052840/？ 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日：EHAF0 doi：10.1093/eurheartj/ehaf0在线印刷。</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40052840/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40052840</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf030>10.1093/eurheartj/ehaf0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator>安东尼贝叶斯 - 天然</dc:creator><dc:date>2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>推动边界：管理110年患者的未知领域</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf0</dc:identifier></item><item><title>促进南亚和东南亚的公平健康寿命</title><link/>https://pubed.nlm.nlm.nlm.gov/4052839/?utm_source=Chrome&amp;utm_medium = rsss＆outm_campaign = pubaign = pubbed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日：EHAF0 doi：10.1093/eurheartj/ehaf0在线印刷。</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40052839/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40052839</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf051>10.1093/eurheartj/ehaf0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Raaj Kishore Biswas</dc:creator><dc:creator>尼古拉斯·科梅尔（Nicholas Koemel）</dc:creator><dc:creator> Luigi Fontana</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>促进南亚和东南亚的公平健康寿命</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf0</dc:identifier></item><item><title>欧洲心脏肿瘤学会委员会的更新</title><link/>https://pubed.ncbi.nlm.nlm.gov/4052835/？ 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日：EHAF0 doi：10.1093/eurheartj/ehaf0在线印刷。</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40052835/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40052835</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehaf052>10.1093/eurheartj/ehaf0</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> TeresaLópez-Fernández</dc:creator><dc:creator>彼得·范·德·梅尔·梅尔</dc:creator><dc:creator>亚历山大·里昂</dc:creator><dc:date>2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>欧洲心脏肿瘤学会委员会的更新</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf0</dc:identifier></item><item><title> SGLT2抑制剂：不适合高血压，而是在高血压中非常适当</title><link/>https://pubed.ncbi.nlm.nlm.gov/40052832/？ 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>如果抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> EUR HEART J. 2025 3月7日：Ehae7 doi：10.1093/eurheartj/ehae7在线印刷。</p><p><b>如果抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/40052832/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40052832</a> | doi： <a href=https://doi.org/10.1093/eurheartj/ehae751>10.1093/eurheartj/ehae7</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> PubMed：4</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator>弗朗兹·H·梅塞利利（Franz H Messerlili）</dc:creator><dc:creator>肾脏的Schoenenberger-Berzins</dc:creator><dc:creator>米歇尔·伯尼尔（Michel Burnier）</dc:creator><dc:date> 2025-03-0</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>SGLT2抑制剂：不适合高血压，而是在高血压中非常适当</dc:title><dc:identifier>PMID：4</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehae7</dc:identifier></item><item><title>心脏移植中的临床结果与正常热脉冲器官灌注：OCS心脏灌注注册表的报告</title><link/>https://pubed.ncbi.nlm.nlm.gov/40052272/?utm_source = chrome&amp;utm_medium = rsss＆outm_campaign = pubaign = pubbed-2&amp;utm_content = 1VUEPJ4Z_TESAAXKWJXBOGOTAABXD6U-NVU80003KRCPQ-＆FC = 20230704047＆ff = 202509161020＆v = 2.18.0.e4<description>结论：我们证明，对DBD捐赠者的OCS实施（主要使用专用恢复团队）与扩展的供体标准，更长的运输距离和出色的后置式后结果有关。在OCS-DCD供体中，结果与NRP-DCD恢复的捐赠者的结果平行，并与DBD供体器官进行比较。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>2025年3月7日DOI：10.1161/CirculationAha.124.0在线印刷。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：一种保存系统，器官护理系统（OCS； Transmmedics）在器官传输过程中使用正常的热脉冲灌注进行心脏移植。该系统在脑死亡后（DBD）和循环死亡（DCD）后从扩展的标准供体（DBD）中恢复的心脏中表现出了有利的结果。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：OCS心脏灌注注册表使用OCS，静态冷藏（SC）或从DCD供体中恢复的OCS，静态冷藏（SCS）或胸腔正常热区域灌注（NRP）收集有关美国心脏移植的数据。与来自DCD供体的SCS心脏和OCS心脏相比，我们分析了用OCS供体心脏（DBD或DCD）移植的患者（DBD或DCD）的患者中的供体和受体特征和移植后结果。倾向得分匹配用于生存分析以调整受体特征之间的差异。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在2021年至2023年之间，在心脏灌注注册表中分析了从56个中心招募的3225个心脏移植。 The OCS was used in 854 of 3225 heart transplantations (26.4%), among which 340 (39.8%) were DBD and 514 (60.2%) were DCD donors, whereas 2174 DBD donors were recovered with SCS and another 197 DCD donors with NRP techniques. The OCS-DBD group experienced a greater number of organ offer refusals before final acceptance (13 versus 6; Wilcoxon rank sum, <i>P</i> &lt;0.001) and a longer transport distance (667 miles versus 232 miles; Wilcoxon rank sum, <i>P</i> &lt;0.001) compared with SCS-DBD. Survival at 12 months was similar between the 2 groups (89.9% for OCS-DBD versus 90.6% for SCS-DBD; marginal Cox model, <i>P</i> =0.54). Among the OCS-DCD and SCS-DBD groups, survival at 12 months was also similar (91.0% versus 92.5%, respectively; marginal Cox model, <i>P</i> =0.32). The OCS-DCD and NRP-DCD groups demonstrated similar survival (91.0% versus 91.7%, respectively; log rank, <i>P</i> =0.63), although the transport distance was longer in OCS-DCD compared with DCD with NRP followed by SCS (400 miles versus 223 miles; Wilcoxon rank sum, <i>P</i> &lt;0.001). By 2023, 90% of all OCS donor management and recovery was performed with dedicated organ recovery teams. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: We demonstrate that real-world implementation of the OCS for DBD donors (using predominantly a dedicated recovery team) is associated with expanded donor criteria, longer transport distance, and excellent posttransplantation outcomes. In OCS-DCD donors, outcomes parallel those of donors recovered with NRP-DCD and compare favorably with DBD donor organs.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40052272/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40052272</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071743>10.1161/CIRCULATIONAHA.124.071743</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> pubmed:40052272</guid><pubDate> Fri, 07 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Josef Stehlik</dc:creator><dc:creator> Maryjane A Farr</dc:creator><dc:creator> Mandeep R Mehra</dc:creator><dc:creator> Jacob N Schroder</dc:creator><dc:creator> David A D&#39;Alessandro</dc:creator><dc:creator> Jay D Pal</dc:creator><dc:creator> Mauricio A Villavicencio</dc:creator><dc:creator> Peter J Gruber</dc:creator><dc:creator> Gregory S Couper</dc:creator><dc:creator> Yasuhiro Shudo</dc:creator><dc:creator> Parag C Patel</dc:creator><dc:creator> Mani A Daneshmand</dc:creator><dc:creator> Liviu Klein</dc:creator><dc:creator> Ashish S Shah</dc:creator><dc:creator> Eric R Skipper</dc:creator><dc:creator> Fardad Esmailian</dc:creator><dc:creator> Daniel Goldstein</dc:creator><dc:creator> Suguru Ohira</dc:creator><dc:creator> Lucian Lozonschi</dc:creator><dc:creator> David J Kaczorowski</dc:creator><dc:creator> Koji Takeda</dc:creator><dc:creator> Rajasekhar SR Malyala</dc:creator><dc:creator> Jonathan W Haft</dc:creator><dc:creator> Dan M Meyer</dc:creator><dc:creator> Benjamin C Sun</dc:creator><dc:creator> Victor Pretorius</dc:creator><dc:creator> Arman Kilic</dc:creator><dc:creator> Anelechi C Anyanwu</dc:creator><dc:creator> Celeste T Williams</dc:creator><dc:creator> Duc T Pham</dc:creator><dc:creator> Masashi Kai</dc:creator><dc:creator> Nasir Z Sulemanjee</dc:creator><dc:creator> Akinobu Itoh</dc:creator><dc:creator> Masaki Funamoto</dc:creator><dc:creator> Christopher T Salerno</dc:creator><dc:creator> John S Ikonomidis</dc:creator><dc:creator> Lucian A Durham</dc:creator><dc:creator> Andrew Shaffer</dc:creator><dc:creator> Xiang Zhou</dc:creator><dc:creator> Farhan Zafar</dc:creator><dc:creator> Sean P Pinney</dc:creator><dc:creator> Carmelo A Milano</dc:creator><dc:date> 2025-03-0</dc:date><dc:source> Circulation</dc:source><dc:title> Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry</dc:title><dc:identifier> pmid:40052272</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.124.071743</dc:identifier></item><item><title> The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence</title><link/> https://pubmed.ncbi.nlm.nih.gov/40049585/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250309161020&amp;v=2.18.0.post9+e462414<description> CONCLUSIONS: The findings support the hypothesis that SCAD is primarily caused by intramural bleeding, with a harmful association of more potent antiplatelet therapy and anticoagulation with adverse cardiovascular outcomes. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025 Mar 7:ehaf097. doi: 10.1093/eurheartj/ehaf097. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND AND AIMS: Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome (ACS). Recent data suggest a harmful association of dual antiplatelet therapy compared with single antiplatelet therapy following SCAD. This study investigated independent predictors of major adverse cardiovascular events (MACEs) and recurrence in patients with SCAD. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: This multicentre cohort study involving 23 Australian and New Zealand sites included patients aged ≥18 years with an ACS due to SCAD confirmed on core laboratory adjudication. Multivariable Cox proportional hazard models analysed predictors for the primary MACE outcome. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Among 586 patients, 505 (150 prospective, 355 retrospective) with SCAD confirmed by core laboratory adjudication, mean age was 52.2 ± 10.6 years, 88.6% were female, and 74.5% were Caucasian. At long-term follow-up (median 21 months), MACE and SCAD recurrence occurred in 8.6% and 3.6% of patients, respectively. Oral anticoagulation on discharge [adjusted hazard ratio (aHR) 3.8, 95% confidence interval (CI) 1.6-9.3, P = .003], ticagrelor combined with aspirin (aHR 1.8, 95% CI 1.04-3.2, P = .037), fibromuscular dysplasia (aHR 2.2, 95% CI 1.05-4.5, P = .037), and history of stroke (aHR 3.8, 95% CI 1.2-12.2, P = .03) were independently associated with higher MACE. Fibromuscular dysplasia (aHR 3.9, 95% CI 1.5-26.5, P = .01), ticagrelor combined with aspirin (aHR 2.6, 95% CI 2.1-5.3, P = .01), and history of stroke (aHR 6.2, 95% CI 1.8-9.5, P = .01) were also associated with higher SCAD recurrence. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: The findings support the hypothesis that SCAD is primarily caused by intramural bleeding, with a harmful association of more potent antiplatelet therapy and anticoagulation with adverse cardiovascular outcomes.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40049585/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250309161020&v=2.18.0.post9+e462414">40049585</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehaf097>10.1093/eurheartj/ehaf097</a></p></div> ]]]]]</content:encoded><guid ispermalink="false"> pubmed:40049585</guid><pubDate> Thu, 06 Mar 2025 06:00:00 -0500</pubDate><dc:creator> Quan M Dang</dc:creator><dc:creator> Peter J Psaltis</dc:creator><dc:creator> Sonya Burgess</dc:creator><dc:creator> Jaya Chandrasekhar</dc:creator><dc:creator> Swati Mukherjee</dc:creator><dc:creator> Leonard Kritharides</dc:creator><dc:creator> Nigel Jepson</dc:creator><dc:creator> Sarah Fairley</dc:creator><dc:creator> Abdul Ihdayhid</dc:creator><dc:creator> Jamie Layland</dc:creator><dc:creator> Richard Szirt</dc:creator><dc:creator> Seif El-Jack</dc:creator><dc:creator> Aniket Puri</dc:creator><dc:creator> Esther Davis</dc:creator><dc:creator> Imran Shiekh</dc:creator><dc:creator> Ruth Arnold</dc:creator><dc:creator> Monique Watts</dc:creator><dc:creator> Jessica A Marathe</dc:creator><dc:creator> Rohan Bhagwandeen</dc:creator><dc:creator> Edwina Wing-Lun</dc:creator><dc:creator> Ravinay Bhindi</dc:creator><dc:creator> Tom Ford</dc:creator><dc:creator> Sidney Lo</dc:creator><dc:creator> Simone Marschner</dc:creator><dc:creator> Sarah Zaman</dc:creator><dc:date> 2025-03-06</dc:date><dc:source> European heart journal</dc:source><dc:title> The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence</dc:title><dc:identifier> pmid:40049585</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehaf097</dc:identifier></item></channel></rss>